These three names get used as though they were competing brands of the same product. They are not. Each acts on a different combination of gut and metabolic hormone receptors, and that difference is the whole story. Semaglutide targets one receptor. Tirzepatide targets two. Retatrutide targets three, and it is not FDA approved, which matters more than any comparison of expected results.
The short version
- GLP-1 receptor agonists such as semaglutide act on a single receptor, GLP-1. Approved and widely used.
- Tirzepatide acts on two, GIP and GLP-1. Approved.
- Retatrutide acts on three, GIP, GLP-1 and glucagon. Investigational. No one can prescribe it as an approved medicine today.
What GLP-1 actually does
GLP-1 is a hormone your gut releases when you eat. It slows how quickly the stomach empties, prompts insulin release when glucose is high, and signals fullness to the brain. Semaglutide and similar drugs imitate that hormone at a far higher and steadier level than a meal ever would.
The lived experience is a change in appetite rather than willpower. Meals end sooner. The mental background noise about food quietens. That last effect is the one patients most often describe as the thing that finally made a difference, because it is the part diets never address.
The common side effects follow directly from the mechanism: nausea, reflux, constipation or loose stools, especially while the dose is increasing. Most are manageable with slower escalation and adjusted eating patterns, which is a large part of what supervision is for.
What tirzepatide adds
Tirzepatide activates GIP as well as GLP-1. GIP is a second gut hormone involved in insulin release and fat handling, and adding it appears to improve both blood-sugar control and weight outcomes relative to targeting GLP-1 alone. In trials, average weight reduction with tirzepatide has been greater than with semaglutide.
“On average” deserves emphasis. Individual response varies widely, and the person in front of you is not an average. Some people do very well on semaglutide and gain nothing from switching. Tolerability also differs between the two, and the drug you can actually stay on beats the one with the better trial number.
What retatrutide is, and is not
Retatrutide adds a third target, the glucagon receptor. Glucagon raises energy expenditure and affects how the liver handles fat, so the theory is that a triple agonist could produce more weight loss than either drug above.
The Phase 3 programme, TRIUMPH, studied it in more than 5,800 participants across obesity, obstructive sleep apnea and knee osteoarthritis, and the manufacturer has reported positive results and stated an intention to file for United States approval in 2027.
Until a regulator reviews that filing, retatrutide remains investigational. It is not available by prescription in the United States, and it is not something this clinic or any other can legitimately offer you as an approved treatment. If a website offers to sell you retatrutide today, what is on offer is an unapproved compound of unverified content, outside any framework that checks purity, dose or sterility. Please do not.
The question that matters more than which drug
Whichever medication you and your provider choose, the same two things determine whether the result lasts.
Protecting muscle. Rapid weight loss costs lean tissue as well as fat, and lean tissue is what keeps your metabolic rate up, your blood sugar stable and your body durable as you age. That means enough protein, resistance training that continues throughout, and tracking body composition rather than only the scale number.
Planning for after. Appetite regulation returns when the medication stops. A plan that has no answer for month thirteen is not a plan, it is a prescription. This is the single most common reason people regain, and it is entirely foreseeable.
Who these drugs are not for
They are not appropriate for everyone. A proper consult reviews personal and family history of medullary thyroid carcinoma and MEN2, pancreatitis, gallbladder disease, severe gastrointestinal conditions, pregnancy or plans for pregnancy, and your full medication list. Screening for those is not a formality, and a service that skips it is skipping the part that protects you.
How we approach it
Medical weight loss here is supervised care, not a subscription to an injection. That means baseline labs, a medication choice matched to your history and tolerance rather than to what is fashionable, dose escalation paced to your symptoms, attention to protein and resistance training from week one, and a defined plan for maintenance.
If fatigue, low drive and stalled progress are part of your picture, hormones may be a second thread worth pulling. Signs of low testosterone, and when to test covers that side, and gut symptoms have their own workup in what a GI-MAP test actually shows.
Consults are available in person at our Deerfield Beach clinic and by telehealth anywhere in Florida.
Medically reviewed by Krishna Borges, MSN, APRN, FNP-C. This article is for general education and is not a substitute for individual medical advice.